CRS3123
CRS3123 is a potent and orally active narrow-spectrum antibiotic. CRS3123 inhibits bacterial methionyl-tRNA synthetase. CRS3123 has potent activity against Clostridium difficile (C. difficile) and aerobic Gram-positive bacteria but little activity against Gram-negative bacteria, including anaerobes. CRS3123 has the potential for the research of C. difficile infections[1].
Product Specifications
CAS Number
1013915-71-3
Product Name Alternative
REP-3123
UNSPSC
12352005
Target
Antibiotic
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/crs3123.html
Purity
99.37
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
BrC1=C(OCC2)C([C@@H]2NCCCNC3=CC(C(SC=C4)=C4N3)=O)=CC(Br)=C1
Molecular Formula
C19H19Br2N3O2S
Molecular Weight
513.25
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Phospho-Kv2.1 (Tyr128) Rabbit Polyclonal Antibody (BF647)
CDCA7L (CDCA7L, HR1, JPO2, R1, Cell Division Cycle-Associated 7-like Protein, Cell Division Cycle-Associated 7-like Protein, Protein JPO2, Cell Division Cycle-Associated 7-like Protein, Transcription Factor RAM2) (MaxLight 405) discontinued
